These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21245434)

  • 1. TNM staging in colorectal cancer: T is for T cell and M is for memory.
    Broussard EK; Disis ML
    J Clin Oncol; 2011 Feb; 29(6):601-3. PubMed ID: 21245434
    [No Abstract]   [Full Text] [Related]  

  • 2. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.
    Mlecnik B; Tosolini M; Kirilovsky A; Berger A; Bindea G; Meatchi T; Bruneval P; Trajanoski Z; Fridman WH; Pagès F; Galon J
    J Clin Oncol; 2011 Feb; 29(6):610-8. PubMed ID: 21245428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
    Galon J; Costes A; Sanchez-Cabo F; Kirilovsky A; Mlecnik B; Lagorce-Pagès C; Tosolini M; Camus M; Berger A; Wind P; Zinzindohoué F; Bruneval P; Cugnenc PH; Trajanoski Z; Fridman WH; Pagès F
    Science; 2006 Sep; 313(5795):1960-4. PubMed ID: 17008531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients.
    Deng L; Zhang H; Luan Y; Zhang J; Xing Q; Dong S; Wu X; Liu M; Wang S
    Clin Cancer Res; 2010 Aug; 16(16):4105-12. PubMed ID: 20682706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
    Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
    J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical utility of the local inflammatory response in colorectal cancer.
    Richards CH; Roxburgh CS; Powell AG; Foulis AK; Horgan PG; McMillan DC
    Eur J Cancer; 2014 Jan; 50(2):309-19. PubMed ID: 24103145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated antigen recognized by the 22-1-1 monoclonal antibody encourages colorectal cancer progression under the scanty CD8+ T cells.
    Oshikiri T; Miyamoto M; Morita T; Fujita M; Miyasaka Y; Senmaru N; Yamada H; Takahashi T; Horita S; Kondo S
    Clin Cancer Res; 2006 Jan; 12(2):411-6. PubMed ID: 16428480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.
    Pagès F; Kirilovsky A; Mlecnik B; Asslaber M; Tosolini M; Bindea G; Lagorce C; Wind P; Marliot F; Bruneval P; Zatloukal K; Trajanoski Z; Berger A; Fridman WH; Galon J
    J Clin Oncol; 2009 Dec; 27(35):5944-51. PubMed ID: 19858404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell response to p53 tumor-associated antigen in patients with colorectal carcinoma.
    Bueter M; Gasser M; Schramm N; Lebedeva T; Tocco G; Gerstlauer C; Grimm M; Nichiporuk E; Thalheimer A; Thiede A; Meyer D; Benichou G; Waaga-Gasser AM
    Int J Oncol; 2006 Feb; 28(2):431-8. PubMed ID: 16391798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour T-lymphocyte subset infiltration and tumour recurrence following curative resection for colorectal cancer.
    Ali AA; McMillan DC; Matalka II; McNicol AM; McArdle CS
    Eur J Surg Oncol; 2004 Apr; 30(3):292-5. PubMed ID: 15028311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastases.
    Katz SC; Pillarisetty V; Bamboat ZM; Shia J; Hedvat C; Gonen M; Jarnagin W; Fong Y; Blumgart L; D'Angelica M; DeMatteo RP
    Ann Surg Oncol; 2009 Sep; 16(9):2524-30. PubMed ID: 19568816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell subsets and colorectal cancer: discerning the good from the bad.
    Scurr M; Gallimore A; Godkin A
    Cell Immunol; 2012 Sep; 279(1):21-4. PubMed ID: 23041206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The essential role of the in situ immune reaction in human colorectal cancer.
    Pagès F; Galon J; Fridman WH
    J Leukoc Biol; 2008 Oct; 84(4):981-7. PubMed ID: 18559950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases.
    Gulubova M; Manolova I; Kyurkchiev D; Julianov A; Altunkova I
    APMIS; 2009 Dec; 117(12):870-9. PubMed ID: 20078551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer.
    Simpson JA; Al-Attar A; Watson NF; Scholefield JH; Ilyas M; Durrant LG
    Gut; 2010 Jul; 59(7):926-33. PubMed ID: 20581241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma.
    Watanabe Y; Katou F; Ohtani H; Nakayama T; Yoshie O; Hashimoto K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):744-52. PubMed ID: 20303300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma.
    Suzuki A; Masuda A; Nagata H; Kameoka S; Kikawada Y; Yamakawa M; Kasajima T
    J Pathol; 2002 Jan; 196(1):37-43. PubMed ID: 11748640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cells infiltrating colorectal cancer and MHC class I expression.
    Sandel MH; Speetjens FM; Menon AG; Albertsson PA; Basse PH; Hokland M; Nagelkerke JF; Tollenaar RA; van de Velde CJ; Kuppen PJ
    Mol Immunol; 2005 Feb; 42(4):541-6. PubMed ID: 15607811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of CDDP on cytotoxicity of TILs obtained from colorectal tumors].
    Xu Z; Qi X; Liu F
    Zhonghua Wai Ke Za Zhi; 1997 May; 35(5):265-7. PubMed ID: 10374556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.